摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-chloro-2-methyl-6-(2-pyridyl)pyrimidine | 25194-62-1

中文名称
——
中文别名
——
英文名称
4-chloro-2-methyl-6-(2-pyridyl)pyrimidine
英文别名
4-Chloro-2-methyl-6-(pyridin-2-yl)pyrimidine;4-chloro-2-methyl-6-pyridin-2-ylpyrimidine
4-chloro-2-methyl-6-(2-pyridyl)pyrimidine化学式
CAS
25194-62-1
化学式
C10H8ClN3
mdl
MFCD01646076
分子量
205.647
InChiKey
ZWHZRLMJZKIKGZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    38.7
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists
    摘要:
    The identification of highly potent and orally bioavailable GPR39 agonists is reported. Compound 1, found in a phenotypic screening campaign, was transformed into compound 2 with good activity on both the rat and human GPR39 receptor. This compound was further optimized to improve ligand efficiency and pharmacokinetic properties to yield GPR39 agonists for the potential oral treatment of type 2 diabetes. Thus, compound 3 is the first potent GPR39 agonist (EC(50)s <= 1 nM for human and rat receptor) that is orally bioavailable in mice and robustly induced acute GLP-1 levels.
    DOI:
    10.1021/ml500240d
  • 作为产物:
    描述:
    皮考林乙酸乙酯potassium carbonate三氯氧磷 作用下, 以 乙醇 为溶剂, 反应 2.0h, 生成 4-chloro-2-methyl-6-(2-pyridyl)pyrimidine
    参考文献:
    名称:
    Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists
    摘要:
    The identification of highly potent and orally bioavailable GPR39 agonists is reported. Compound 1, found in a phenotypic screening campaign, was transformed into compound 2 with good activity on both the rat and human GPR39 receptor. This compound was further optimized to improve ligand efficiency and pharmacokinetic properties to yield GPR39 agonists for the potential oral treatment of type 2 diabetes. Thus, compound 3 is the first potent GPR39 agonist (EC(50)s <= 1 nM for human and rat receptor) that is orally bioavailable in mice and robustly induced acute GLP-1 levels.
    DOI:
    10.1021/ml500240d
点击查看最新优质反应信息

文献信息

  • [EN] PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL<br/>[FR] COMPOSÉ PYRIMIDINE ET SON UTILISATION DANS LA LUTTE ANTIPARASITAIRE
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2010134478A1
    公开(公告)日:2010-11-25
    A pyrimidine compound represented by below formula (I) has excellent control activity against pests and is useful as an active ingredient of a pest controlling agent.
    以下公式(I)所代表的嘧啶化合物对害虫具有出色的控制活性,并可用作杀虫剂的活性成分。
  • PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL
    申请人:Mizuno Hajime
    公开号:US20120041009A1
    公开(公告)日:2012-02-16
    A pyrimidine compound represented by below formula (I) has excellent control activity against pests and is useful as an active ingredient of a pest controlling agent.
    下面公式(I)所表示的嘧啶化合物具有优异的害虫控制活性,并且可用作害虫控制剂的活性成分。
  • Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists
    作者:Stefan Peukert、Richard Hughes、Jill Nunez、Guo He、Zhao Yan、Rishi Jain、Luis Llamas、Sarah Luchansky、Adam Carlson、Guiqing Liang、Vidya Kunjathoor、Mike Pietropaolo、Jeffrey Shapiro、Anja Castellana、Xiaoping Wu、Avirup Bose
    DOI:10.1021/ml500240d
    日期:2014.10.9
    The identification of highly potent and orally bioavailable GPR39 agonists is reported. Compound 1, found in a phenotypic screening campaign, was transformed into compound 2 with good activity on both the rat and human GPR39 receptor. This compound was further optimized to improve ligand efficiency and pharmacokinetic properties to yield GPR39 agonists for the potential oral treatment of type 2 diabetes. Thus, compound 3 is the first potent GPR39 agonist (EC(50)s <= 1 nM for human and rat receptor) that is orally bioavailable in mice and robustly induced acute GLP-1 levels.
查看更多